Health & Biotech
Compumedics inks $1m deal with leading researchers for sleep monitoring device
Aussie researchers and ASX biotechs driving paediatric drug breakthroughs
ASX medtechs chasing FDA De Novo for a shot at big US markets
EMVision advances its AI-driven stroke diagnostics
Health Check: Mayne Pharma shares tumble after suitor threatens to walk over ‘adverse events’
Biocurious: Avita Medical gets skin in more games with its wider wound care push
LTR Pharma stretches ED treatment reach through major pharmacy chain
Visionflex teams with BHP to deliver virtual healthcare across remote WA sites
Dr Boreham’s Crucible: Can this biotech emerge from Mesoblast’s shadow and ride ‘stem cells 2.0’?
US Medicare coverage grows for Lumos’ FebriDx point-of-care respiratory test
Health Check: Biotechs obey the Three Commandments of life sciences
Gut Instinct: ASX health stocks tap into rising awareness of microbiome
Scott Power: ASX health stocks up as Trump’s bark proves worse than bite
Health Check: Amplia shares surge on pancreatic cancer trial results; Immutep offers hope
Orthocell grows US distributors for nerve repair product to 12
Biocurious: With its ‘molecular Lego’ approach, Arovella is building hope for cancer patients one brick at a time
Lumos secures iMedical US$126k purchase order for FebriDx respiratory tests
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
